2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; a new class of potent, selective and orally active glycogen synthase kinase-3β inhibitors

Kenji Fukunaga; Fumiaki Uehara; Keiichi Aritomo; Aya Shoda; Shinsuke Hiki; Masahiro Okuyama; Yoshihiro Usui; Kazutoshi Watanabe; Koichi Yamakoshi; Toshiyuki Kohara; Tokushi Hanano; Hiroshi Tanaka; Susumu Tsuchiya; Shinji Sunada; Ken-Ichi Saito; Jun-ichi Eguchi; Satoshi Yuki; Shoichi Asano; Shinji Tanaka; Akiko Mori; Keiji Yamagami; Hiroshi Baba; Takashi Horikawa; Masatake Fujimura

Bioorganic & Medicinal Chemistry Letters (2013) - Comments
pubmed: 24176395 doi: 10.1016/j.bmcl.2013.09.020 issn: 1464-3405 issn: 0960-894x

Kenji Fukunaga, Fumiaki Uehara, Keiichi Aritomo, Aya Shoda, Shinsuke Hiki, Masahiro Okuyama, Yoshihiro Usui, Kazutoshi Watanabe, Koichi Yamakoshi, Toshiyuki Kohara, Tokushi Hanano, Hiroshi Tanaka, Susumu Tsuchiya, Shinji Sunada, Ken-Ichi Saito, Jun-ichi Eguchi, Satoshi Yuki, Shoichi Asano, Shinji Tanaka, Akiko Mori